Theravance Biopharma Inc. (TBPH) NASDAQ
$9.85 0.46 (4.90%)
Market Cap: $478.32M
As of 05/15/24 04:00 PM EDT. Market closed.
Theravance Biopharma Inc. (TBPH)
NASDAQ
$9.85
0.46 (4.90%)
Market Cap: $478.32M
As of 05/15/24 04:00 PM EDT. Market closed.
Add to Portfolio
theravance biopharma is a biopharmaceutical company with one approved product, vibativ® (telavancin), that was discovered and developed internally, a pipeline of internally discovered product candidates and strategic collaborations with pharmaceutical ... read more
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
CEO
Rick Winningham
Full Time Employees
270
CEO Compensation (Base)
$956,600
CEO Compensation (Total)
$2.52M
URL
Address
Ugland House, South Church Street, Grand Cayman, George Town, KY1-1104.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
CEO
Rick Winningham
Full Time Employees
270
CEO Compensation (Base)
$956,600
CEO Compensation (Total)
$2.52M
URL
Address
Ugland House, South Church Street, Grand Cayman, George Town, KY1-1104.
PRICE CHART FOR THERAVANCE BIOPHARMA INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$9.57
Previous Close
$9.39
Days Range
$9.42 - $9.93
52 week range
$8.21 - $11.71
Volume
285,699
Avg. Volume (30 days)
419,518
Market Cap
$478.32M
Dividend Yield
-
P/E
(8.67)
Shares Outstanding
48,559,955
Open
$9.57
Previous Close
$9.39
Days Range
$9.42 - $9.93
52 week range
$8.21 - $11.71
Volume
285,699
Avg. Volume (30 days)
419,518
Market Cap
$478.32M
Dividend Yield
-
P/E
(8.67)
Shares Outstanding
48,559,955
FINANCIAL STATEMENTS FOR THERAVANCE BIOPHARMA INC
LOADING...
INSIDER TRANSACTIONS FOR THERAVANCE BIOPHARMA INC
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Samaha Eli | 10% Owner | May 01, 2024 | Buy | $8.75 | 1,499,124 | 13,117,335 | 8,511,350 | May 03, 2024, 04:19 PM |
Winningham Rick E | CHIEF EXECUTIVE OFFICER | Mar 15, 2024 | Option Exercise | $8.64 | 2,704 | 23,363 | 1,561,473 | Mar 19, 2024, 06:06 PM |
Winningham Rick E | CHIEF EXECUTIVE OFFICER | Feb 20, 2024 | Option Exercise | $8.92 | 37,196 | 331,788 | 1,558,769 | Feb 22, 2024, 08:14 PM |
Sawaf Aziz | SVP & CHIEF FINANCIAL OFFICER | Feb 20, 2024 | Option Exercise | $8.92 | 17,036 | 151,961 | 238,636 | Feb 22, 2024, 08:11 PM |
Miller Aine | SVP, DEV & HEAD OF IRE OFFICE | Feb 20, 2024 | Option Exercise | $8.92 | 11,782 | 105,095 | 133,534 | Feb 22, 2024, 08:10 PM |
Grimaud Brett A. | SVP, GEN COUNSEL AND SECRETARY | Feb 20, 2024 | Option Exercise | $8.92 | 17,595 | 156,947 | 260,684 | Feb 22, 2024, 08:08 PM |
GRAHAM RICHARD A | SVP, RESEARCH & DEVELOPMENT | Feb 20, 2024 | Option Exercise | $8.92 | 19,294 | 172,102 | 314,915 | Feb 22, 2024, 08:06 PM |
Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | Feb 20, 2024 | Option Exercise | $8.92 | 18,219 | 162,513 | 312,987 | Feb 22, 2024, 08:04 PM |
Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | Feb 22, 2024 | Sale | $8.71 | 1,254 | 10,922 | 311,733 | Feb 22, 2024, 08:04 PM |
Winningham Rick E | CHIEF EXECUTIVE OFFICER | Nov 20, 2023 | Option Exercise | $10.37 | 15,804 | 163,887 | 1,595,965 | Nov 22, 2023, 06:16 PM |
Sawaf Aziz | SVP & CHIEF FINANCIAL OFFICER | Nov 20, 2023 | Option Exercise | $10.37 | 6,187 | 64,159 | 255,672 | Nov 22, 2023, 06:14 PM |
Grimaud Brett A. | SVP, GEN COUNSEL AND SECRETARY | Nov 20, 2023 | Option Exercise | $10.37 | 7,363 | 76,354 | 278,279 | Nov 22, 2023, 06:11 PM |
GRAHAM RICHARD A | SVP, RESEARCH & DEVELOPMENT | Nov 20, 2023 | Option Exercise | $10.37 | 12,630 | 130,973 | 334,209 | Nov 22, 2023, 06:10 PM |
Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | Nov 20, 2023 | Option Exercise | $10.37 | 7,982 | 82,773 | 332,584 | Nov 22, 2023, 06:07 PM |
Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | Nov 21, 2023 | Sale | $10.29 | 1,378 | 14,180 | 331,206 | Nov 22, 2023, 06:07 PM |
GRAHAM RICHARD A | SVP, RESEARCH & DEVELOPMENT | Nov 14, 2023 | Sale | $10.22 | 2,482 | 25,366 | 346,839 | Nov 16, 2023, 06:16 PM |
GRAHAM RICHARD A | SVP, RESEARCH & DEVELOPMENT | Oct 16, 2023 | Sale | $9.03 | 2,482 | 22,412 | 334,321 | Oct 18, 2023, 06:54 PM |
GRAHAM RICHARD A | SVP, RESEARCH & DEVELOPMENT | Sep 14, 2023 | Sale | $9.89 | 2,482 | 24,547 | 336,803 | Sep 18, 2023, 06:08 PM |
Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | Aug 22, 2023 | Sale | $9.47 | 1,807 | 17,112 | 340,566 | Aug 24, 2023, 06:05 PM |
Winningham Rick E | CHIEF EXECUTIVE OFFICER | Aug 20, 2023 | Option Exercise | $9.70 | 15,804 | 153,299 | 1,611,769 | Aug 22, 2023, 06:19 PM |
Sawaf Aziz | SVP & CHIEF FINANCIAL OFFICER | Aug 20, 2023 | Option Exercise | $9.70 | 7,114 | 69,006 | 261,859 | Aug 22, 2023, 06:17 PM |
Grimaud Brett A. | SVP, GEN COUNSEL AND SECRETARY | Aug 20, 2023 | Option Exercise | $9.70 | 8,912 | 86,446 | 285,297 | Aug 22, 2023, 06:15 PM |
GRAHAM RICHARD A | SVP, RESEARCH & DEVELOPMENT | Aug 20, 2023 | Option Exercise | $9.70 | 10,461 | 101,472 | 339,285 | Aug 22, 2023, 06:13 PM |
Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | Aug 20, 2023 | Option Exercise | $9.70 | 10,460 | 101,462 | 342,373 | Aug 22, 2023, 06:10 PM |
GRAHAM RICHARD A | SVP, RESEARCH & DEVELOPMENT | Aug 11, 2023 | Sale | $9.99 | 2,322 | 23,197 | 349,746 | Aug 15, 2023, 06:09 PM |
GRAHAM RICHARD A | SVP, RESEARCH & DEVELOPMENT | Jul 14, 2023 | Sale | $9.84 | 2,322 | 22,848 | 352,068 | Jul 18, 2023, 06:14 PM |
GRAHAM RICHARD A | SVP, RESEARCH & DEVELOPMENT | Jun 14, 2023 | Sale | $10.69 | 2,322 | 24,822 | 354,390 | Jun 16, 2023, 06:14 PM |
Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | Jun 08, 2023 | Sale | $11.13 | 1,790 | 19,923 | 352,833 | Jun 12, 2023, 06:08 PM |
Winningham Rick E | CHIEF EXECUTIVE OFFICER | May 20, 2023 | Option Exercise | $11.21 | 15,804 | 177,163 | 1,627,573 | May 23, 2023, 07:48 PM |
Sawaf Aziz | SVP & CHIEF FINANCIAL OFFICER | May 20, 2023 | Option Exercise | $11.21 | 8,744 | 98,020 | 268,973 | May 23, 2023, 07:46 PM |
Grimaud Brett A. | SVP, GEN COUNSEL AND SECRETARY | May 20, 2023 | Option Exercise | $11.21 | 11,469 | 128,567 | 294,209 | May 23, 2023, 07:44 PM |
GRAHAM RICHARD A | SVP, RESEARCH & DEVELOPMENT | May 20, 2023 | Option Exercise | $11.21 | 10,460 | 117,257 | 356,712 | May 23, 2023, 07:41 PM |
Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | May 20, 2023 | Option Exercise | $11.21 | 5,567 | 62,406 | 354,623 | May 23, 2023, 07:40 PM |
GRAHAM RICHARD A | SVP, RESEARCH & DEVELOPMENT | May 15, 2023 | Sale | $11.26 | 2,322 | 26,146 | 367,172 | May 17, 2023, 06:17 PM |
GRAHAM RICHARD A | SVP, RESEARCH & DEVELOPMENT | Apr 14, 2023 | Sale | $11.88 | 2,323 | 27,597 | 369,494 | Apr 18, 2023, 05:49 PM |
GRAHAM RICHARD A | SVP, RESEARCH & DEVELOPMENT | Mar 14, 2023 | Sale | $10.32 | 2,323 | 23,973 | 371,817 | Mar 16, 2023, 07:04 PM |
Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | Mar 09, 2023 | Sale | $10.20 | 4,000 | 40,800 | 360,190 | Mar 13, 2023, 05:57 PM |
GRAHAM RICHARD A | SVP, RESEARCH & DEVELOPMENT | Mar 06, 2023 | Sale | $10.05 | 2,323 | 23,346 | 374,140 | Mar 08, 2023, 07:34 PM |
Winningham Rick E | CHIEF EXECUTIVE OFFICER | Feb 20, 2023 | Option Exercise | $10.44 | 37,420 | 390,665 | 1,313,377 | Feb 22, 2023, 07:29 PM |
Sawaf Aziz | SVP & CHIEF FINANCIAL OFFICER | Feb 20, 2023 | Option Exercise | $10.44 | 6,783 | 70,815 | 197,717 | Feb 22, 2023, 07:27 PM |
Grimaud Brett A. | SVP, GEN COUNSEL AND SECRETARY | Feb 20, 2023 | Option Exercise | $10.44 | 10,198 | 106,467 | 229,958 | Feb 22, 2023, 07:23 PM |
GRAHAM RICHARD A | SVP, RESEARCH & DEVELOPMENT | Feb 20, 2023 | Option Exercise | $10.44 | 12,057 | 125,875 | 301,463 | Feb 22, 2023, 07:21 PM |
Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | Feb 20, 2023 | Option Exercise | $10.44 | 7,119 | 74,322 | 289,190 | Feb 22, 2023, 07:18 PM |
Winningham Rick E | CHIEF EXECUTIVE OFFICER | Dec 14, 2022 | Sale | $11.19 | 50,000 | 559,500 | 1,350,797 | Dec 16, 2022, 07:36 PM |
GRAHAM RICHARD A | SVP, RESEARCH & DEVELOPMENT | Dec 01, 2022 | Sale | $10.73 | 2,084 | 22,361 | 313,520 | Dec 05, 2022, 05:59 PM |
O'Connor Donal | Director | Nov 22, 2022 | Option Exercise | $10.50 | 10,000 | 105,000 | 43,886 | Nov 23, 2022, 06:57 PM |
Winningham Rick E | CHIEF EXECUTIVE OFFICER | Nov 20, 2022 | Option Exercise | $10.85 | 15,804 | 171,473 | 1,409,797 | Nov 22, 2022, 04:09 PM |
Hindman Andrew A. | SVP, CHIEF FINANCIAL OFFICER | Nov 20, 2022 | Option Exercise | $10.85 | 25,057 | 271,868 | 384,714 | Nov 22, 2022, 04:07 PM |
Hindman Andrew A. | SVP, CHIEF FINANCIAL OFFICER | Nov 18, 2022 | Sale | $11.02 | 65,000 | 716,242 | 409,771 | Nov 22, 2022, 04:07 PM |
GRAHAM RICHARD A | SVP, RESEARCH & DEVELOPMENT | Nov 20, 2022 | Option Exercise | $10.85 | 27,350 | 296,748 | 315,604 | Nov 22, 2022, 04:04 PM |
Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | Nov 20, 2022 | Option Exercise | $10.85 | 23,268 | 252,458 | 296,309 | Nov 22, 2022, 04:02 PM |
GRAHAM RICHARD A | SVP, RESEARCH & DEVELOPMENT | Nov 16, 2022 | Option Exercise | $11.20 | 2,800 | 31,360 | 342,954 | Nov 17, 2022, 07:53 PM |
GSK PLC | Former 10% Owner | Sep 16, 2022 | Option Exercise | $9.75 | 9,644,807 | 94,036,868 | 0 | Sep 20, 2022, 04:16 PM |
Winningham Rick E | CHIEF EXECUTIVE OFFICER | Aug 19, 2022 | Option Exercise | $9.34 | 15,804 | 147,609 | 1,424,784 | Aug 23, 2022, 07:03 PM |
Hindman Andrew A. | SVP, CHIEF FINANCIAL OFFICER | Aug 19, 2022 | Option Exercise | $9.34 | 25,676 | 239,814 | 473,507 | Aug 23, 2022, 07:00 PM |
GRAHAM RICHARD A | SVP, DEVELOPMENT | Aug 19, 2022 | Option Exercise | $9.34 | 18,991 | 177,376 | 345,754 | Aug 23, 2022, 06:57 PM |
Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | Aug 19, 2022 | Option Exercise | $9.34 | 10,413 | 97,257 | 319,577 | Aug 23, 2022, 06:54 PM |
GRAHAM RICHARD A | SVP, DEVELOPMENT | Aug 16, 2022 | Sale | $9.71 | 4,906 | 47,640 | 364,745 | Aug 18, 2022, 06:05 PM |
GRAHAM RICHARD A | SVP, DEVELOPMENT | Aug 09, 2022 | Sale | $8.79 | 15,086 | 132,606 | 369,651 | Aug 11, 2022, 06:55 PM |
Winningham Rick E | CHIEF EXECUTIVE OFFICER | May 20, 2022 | Option Exercise | $8.74 | 11,025 | 96,358 | 1,440,588 | May 24, 2022, 07:19 PM |
Hindman Andrew A. | SVP, CHIEF FINANCIAL OFFICER | May 20, 2022 | Option Exercise | $8.74 | 3,365 | 29,410 | 479,183 | May 24, 2022, 07:17 PM |
GRAHAM RICHARD A | SVP, DEVELOPMENT | May 20, 2022 | Option Exercise | $8.74 | 3,947 | 34,497 | 384,737 | May 24, 2022, 07:14 PM |
Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | May 20, 2022 | Option Exercise | $8.74 | 2,200 | 19,228 | 331,071 | May 24, 2022, 07:11 PM |
Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | May 23, 2022 | Sale | $8.93 | 1,081 | 9,653 | 329,990 | May 24, 2022, 07:11 PM |
Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | Feb 28, 2022 | Sale | $10.16 | 2,356 | 23,947 | 333,271 | Mar 02, 2022, 07:08 PM |
Winningham Rick E | CHIEF EXECUTIVE OFFICER | Feb 18, 2022 | Option Exercise | $9.61 | 22,710 | 218,243 | 1,279,300 | Feb 23, 2022, 06:38 PM |
PITZER KENNETH R | SVP, PROD STRAT & COMM PLNG | Feb 18, 2022 | Option Exercise | $9.61 | 27,299 | 262,343 | 380,123 | Feb 23, 2022, 06:34 PM |
Hindman Andrew A. | SVP, CHIEF FINANCIAL OFFICER | Feb 18, 2022 | Option Exercise | $9.61 | 25,973 | 249,601 | 481,285 | Feb 23, 2022, 06:29 PM |
GRAHAM RICHARD A | SVP, DEVELOPMENT | Feb 18, 2022 | Option Exercise | $9.61 | 20,377 | 195,823 | 388,684 | Feb 23, 2022, 06:25 PM |
Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | Feb 18, 2022 | Option Exercise | $9.61 | 11,824 | 113,629 | 335,627 | Feb 23, 2022, 06:22 PM |
BRADY ANN | PRESIDENT, TBIL | Feb 18, 2022 | Option Exercise | $9.61 | 8,369 | 80,426 | 110,319 | Feb 23, 2022, 06:18 PM |
BRADY ANN | PRESIDENT, TBIL | Nov 19, 2021 | Option Exercise | $8.36 | 3,169 | 26,493 | 118,688 | Nov 23, 2021, 08:26 PM |
PASQUALONE FRANK | SVP, CHIEF BUSINESS OFFICER | Nov 19, 2021 | Option Exercise | $8.36 | 3,779 | 31,592 | 429,783 | Nov 23, 2021, 08:25 PM |
PITZER KENNETH R | SVP, PROD STRAT & COMM PLNG | Nov 19, 2021 | Option Exercise | $8.36 | 4,310 | 36,032 | 355,422 | Nov 23, 2021, 08:24 PM |
GRAHAM RICHARD A | SVP, DEVELOPMENT | Nov 19, 2021 | Option Exercise | $8.36 | 4,263 | 35,639 | 169,061 | Nov 23, 2021, 08:23 PM |
Hindman Andrew A. | SVP, CHIEF FINANCIAL OFFICER | Nov 19, 2021 | Option Exercise | $8.36 | 1,350 | 11,286 | 167,258 | Nov 23, 2021, 08:22 PM |
WORBOYS PHILIP D | SVP, RESEARCH & TRANSL SCIENCE | Nov 19, 2021 | Option Exercise | $8.36 | 4,310 | 36,032 | 330,752 | Nov 23, 2021, 08:21 PM |
SABESAN VIJAY | SVP, TECHNICAL OPERATIONS | Nov 19, 2021 | Option Exercise | $8.36 | 5,191 | 43,397 | 235,524 | Nov 23, 2021, 08:21 PM |
Winningham Rick E | CHIEF EXECUTIVE OFFICER | Nov 19, 2021 | Option Exercise | $8.36 | 11,404 | 95,337 | 1,302,010 | Nov 23, 2021, 08:20 PM |
WORBOYS PHILIP D | SVP, Research & Transl Science | Aug 20, 2021 | Option Exercise | $14.05 | 4,307 | 60,513 | 335,062 | Aug 24, 2021, 07:07 PM |
Winningham Rick E | Chief Executive Officer | Aug 20, 2021 | Option Exercise | $14.05 | 11,404 | 160,226 | 1,313,414 | Aug 24, 2021, 07:05 PM |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | Aug 20, 2021 | Option Exercise | $14.05 | 4,307 | 60,513 | 277,831 | Aug 24, 2021, 07:03 PM |
SABESAN VIJAY | SVP, Technical Operations | Aug 20, 2021 | Option Exercise | $14.05 | 5,193 | 72,962 | 240,715 | Aug 24, 2021, 07:01 PM |
PITZER KENNETH R | SVP, Prod Strat & Comm Plng | Aug 20, 2021 | Option Exercise | $14.05 | 4,307 | 60,513 | 359,732 | Aug 24, 2021, 06:59 PM |
PASQUALONE FRANK | SVP, Chief Business Officer | Aug 20, 2021 | Option Exercise | $14.05 | 3,779 | 53,095 | 433,562 | Aug 24, 2021, 06:57 PM |
Hindman Andrew A. | SVP, Chief Financial Officer | Aug 20, 2021 | Option Exercise | $14.05 | 17,464 | 245,369 | 167,380 | Aug 24, 2021, 06:55 PM |
GRAHAM RICHARD A | SVP, Development | Aug 20, 2021 | Option Exercise | $14.05 | 6,819 | 95,807 | 173,205 | Aug 24, 2021, 06:52 PM |
BRADY ANN | President, TBIL | Aug 20, 2021 | Option Exercise | $14.05 | 3,169 | 44,524 | 121,857 | Aug 24, 2021, 06:50 PM |
Winningham Rick E | Chief Executive Officer | May 20, 2021 | Option Exercise | $17.80 | 11,404 | 202,991 | 1,324,818 | May 24, 2021, 06:19 PM |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | May 20, 2021 | Option Exercise | $17.80 | 4,310 | 76,718 | 282,138 | May 24, 2021, 06:18 PM |
GRAHAM RICHARD A | SVP, Development | May 20, 2021 | Option Exercise | $17.80 | 3,410 | 60,698 | 180,024 | May 24, 2021, 06:09 PM |
BRADY ANN | President, TBIL | May 20, 2021 | Option Exercise | $17.80 | 3,169 | 56,408 | 125,026 | May 24, 2021, 06:07 PM |
WORBOYS PHILIP D | SVP, Research & Transl Science | Mar 09, 2021 | Sale | $20.00 | 8,829 | 176,580 | 343,679 | Mar 11, 2021, 07:00 PM |
WORBOYS PHILIP D | SVP, Research & Transl Science | Feb 20, 2021 | Option Exercise | $18.79 | 31,887 | 599,157 | 352,508 | Feb 23, 2021, 06:20 PM |
Winningham Rick E | Chief Executive Officer | Feb 20, 2021 | Option Exercise | $18.79 | 110,348 | 2,073,439 | 1,334,821 | Feb 23, 2021, 06:17 PM |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | Feb 20, 2021 | Option Exercise | $18.79 | 31,869 | 598,819 | 285,047 | Feb 23, 2021, 06:15 PM |
SABESAN VIJAY | SVP, Technical Operations | Feb 20, 2021 | Option Exercise | $18.79 | 8,343 | 156,765 | 249,701 | Feb 23, 2021, 06:13 PM |
PITZER KENNETH R | SVP, Prod Strat & Comm Plng | Feb 20, 2021 | Option Exercise | $18.79 | 31,931 | 599,984 | 368,349 | Feb 23, 2021, 06:10 PM |
PASQUALONE FRANK | SVP, Chief Business Officer | Feb 20, 2021 | Option Exercise | $18.79 | 26,961 | 506,597 | 439,719 | Feb 23, 2021, 06:09 PM |
Hindman Andrew A. | SVP, Chief Financial Officer | Feb 20, 2021 | Option Exercise | $18.79 | 3,984 | 74,859 | 184,704 | Feb 23, 2021, 06:07 PM |
HAUMANN BRETT K | Chief Medical Officer | Feb 20, 2021 | Option Exercise | $18.79 | 35,672 | 670,277 | 242,499 | Feb 23, 2021, 06:05 PM |
GRAHAM RICHARD A | SVP, Development | Feb 20, 2021 | Option Exercise | $18.79 | 6,597 | 123,958 | 182,152 | Feb 23, 2021, 06:03 PM |
BRADY ANN | President, TBIL | Feb 20, 2021 | Option Exercise | $18.79 | 10,092 | 189,629 | 128,195 | Feb 23, 2021, 06:01 PM |
GRAHAM RICHARD A | SVP, Development | Dec 14, 2020 | Sale | $19.47 | 7,500 | 146,058 | 123,749 | Dec 16, 2020, 06:09 PM |
WORBOYS PHILIP D | SVP, Research & Transl Science | Dec 03, 2020 | Sale | $18.00 | 4,246 | 76,428 | 319,395 | Dec 07, 2020, 06:42 PM |
WORBOYS PHILIP D | SVP, Research & Transl Science | Nov 20, 2020 | Option Exercise | $17.21 | 4,807 | 82,728 | 323,641 | Nov 24, 2020, 06:25 PM |
Winningham Rick E | Chief Executive Officer | Nov 20, 2020 | Option Exercise | $17.21 | 13,946 | 240,011 | 1,275,169 | Nov 24, 2020, 06:24 PM |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | Nov 20, 2020 | Option Exercise | $17.21 | 4,807 | 82,728 | 251,916 | Nov 24, 2020, 06:22 PM |
SABESAN VIJAY | SVP, Technical Operations | Nov 20, 2020 | Option Exercise | $17.21 | 3,798 | 65,364 | 193,044 | Nov 24, 2020, 06:21 PM |
PITZER KENNETH R | SVP, Prod Strat & Comm Plng | Nov 20, 2020 | Option Exercise | $17.21 | 4,807 | 82,728 | 335,280 | Nov 24, 2020, 06:19 PM |
PASQUALONE FRANK | SVP, Chief Comm Ops Officer | Nov 20, 2020 | Option Exercise | $17.21 | 4,214 | 72,523 | 401,680 | Nov 24, 2020, 06:17 PM |
HAUMANN BRETT K | Chief Medical Officer | Nov 20, 2020 | Option Exercise | $17.21 | 4,639 | 79,837 | 278,171 | Nov 24, 2020, 06:16 PM |
GRAHAM RICHARD A | SVP, Development | Nov 20, 2020 | Option Exercise | $17.21 | 3,876 | 66,706 | 131,249 | Nov 24, 2020, 06:14 PM |
BRADY ANN | President, TBIL | Nov 20, 2020 | Option Exercise | $17.21 | 2,292 | 39,445 | 98,287 | Nov 24, 2020, 06:13 PM |
WORBOYS PHILIP D | SVP, Research & Transl Science | Aug 20, 2020 | Option Exercise | $18.22 | 4,804 | 87,529 | 328,448 | Aug 24, 2020, 06:38 PM |
WORBOYS PHILIP D | SVP, Research & Transl Science | Aug 20, 2020 | Sale | $18.00 | 17,103 | 307,854 | 333,252 | Aug 24, 2020, 06:38 PM |
Winningham Rick E | Chief Executive Officer | Aug 20, 2020 | Option Exercise | $18.22 | 13,946 | 254,096 | 1,289,115 | Aug 24, 2020, 06:36 PM |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | Aug 20, 2020 | Option Exercise | $18.22 | 4,804 | 87,529 | 256,723 | Aug 24, 2020, 06:34 PM |
SABESAN VIJAY | SVP, Technical Operations | Aug 20, 2020 | Option Exercise | $18.22 | 3,799 | 69,218 | 196,842 | Aug 24, 2020, 06:32 PM |
PITZER KENNETH R | SVP, Prod Strat & Comm Plng | Aug 20, 2020 | Option Exercise | $18.22 | 4,804 | 87,529 | 340,087 | Aug 24, 2020, 06:29 PM |
PASQUALONE FRANK | SVP, Chief Comm Ops Officer | Aug 20, 2020 | Option Exercise | $18.22 | 4,214 | 76,779 | 405,894 | Aug 24, 2020, 06:27 PM |
Hindman Andrew A. | SVP, Chief Financial Officer | Aug 20, 2020 | Option Exercise | $18.22 | 4,323 | 78,765 | 123,135 | Aug 24, 2020, 06:24 PM |
HAUMANN BRETT K | Chief Medical Officer | Aug 20, 2020 | Option Exercise | $18.22 | 4,646 | 84,650 | 307,810 | Aug 24, 2020, 06:21 PM |
HAUMANN BRETT K | Chief Medical Officer | Aug 21, 2020 | Sale | $18.29 | 25,000 | 457,240 | 282,810 | Aug 24, 2020, 06:21 PM |
GRAHAM RICHARD A | SVP, Development | Aug 20, 2020 | Option Exercise | $18.22 | 6,598 | 120,216 | 107,625 | Aug 24, 2020, 06:20 PM |
BRADY ANN | President, TBIL | Aug 20, 2020 | Option Exercise | $18.22 | 2,292 | 41,760 | 100,579 | Aug 24, 2020, 06:19 PM |
WORBOYS PHILIP D | SVP, Research & Transl Science | May 20, 2020 | Option Exercise | $26.67 | 4,807 | 128,203 | 350,355 | May 22, 2020, 06:14 PM |
Winningham Rick E | Chief Executive Officer | May 20, 2020 | Option Exercise | $26.67 | 13,946 | 371,940 | 1,303,061 | May 22, 2020, 06:13 PM |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | May 20, 2020 | Option Exercise | $26.67 | 4,807 | 128,203 | 261,527 | May 22, 2020, 06:11 PM |
SABESAN VIJAY | SVP, Technical Operations | May 20, 2020 | Option Exercise | $26.67 | 3,801 | 101,373 | 200,641 | May 22, 2020, 06:10 PM |
PITZER KENNETH R | SVP, Prod Strat & Comm Plng | May 20, 2020 | Option Exercise | $26.67 | 4,807 | 128,203 | 344,891 | May 22, 2020, 06:09 PM |
PASQUALONE FRANK | SVP, Chief Comm Ops Officer | May 20, 2020 | Option Exercise | $26.67 | 4,214 | 112,387 | 410,108 | May 22, 2020, 06:07 PM |
HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | May 20, 2020 | Option Exercise | $26.67 | 4,212 | 112,334 | 312,456 | May 22, 2020, 06:06 PM |
BRADY ANN | President, TBIL | May 20, 2020 | Option Exercise | $26.67 | 2,292 | 61,128 | 102,871 | May 22, 2020, 06:05 PM |
WORBOYS PHILIP D | SVP, Research & Transl Science | Feb 20, 2020 | Option Exercise | $25.90 | 29,105 | 753,819 | 354,750 | Feb 24, 2020, 07:16 PM |
Winningham Rick E | Chief Executive Officer | Feb 20, 2020 | Option Exercise | $25.90 | 96,850 | 2,508,415 | 1,315,605 | Feb 24, 2020, 07:15 PM |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | Feb 20, 2020 | Option Exercise | $25.90 | 29,402 | 761,512 | 264,932 | Feb 24, 2020, 07:13 PM |
SABESAN VIJAY | SVP, Technical Operations | Feb 20, 2020 | Option Exercise | $25.90 | 7,213 | 186,817 | 203,040 | Feb 24, 2020, 07:12 PM |
PITZER KENNETH R | SVP, Prod Strat & Comm Plng | Feb 20, 2020 | Option Exercise | $25.90 | 29,136 | 754,622 | 349,698 | Feb 24, 2020, 07:11 PM |
PASQUALONE FRANK | SVP, Chief Comm Ops Officer | Feb 20, 2020 | Option Exercise | $25.90 | 24,392 | 631,753 | 412,920 | Feb 24, 2020, 07:10 PM |
Hindman Andrew A. | SVP, Chief Financial Officer | Feb 20, 2020 | Option Exercise | $25.90 | 7,060 | 182,854 | 106,490 | Feb 24, 2020, 07:08 PM |
HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | Feb 20, 2020 | Option Exercise | $25.90 | 33,608 | 870,447 | 316,668 | Feb 24, 2020, 07:07 PM |
BRADY ANN | President, TBIL | Feb 20, 2020 | Option Exercise | $25.90 | 5,948 | 154,053 | 105,163 | Feb 24, 2020, 07:05 PM |
SABESAN VIJAY | SVP, Technical Operations | Dec 12, 2019 | Sale | $21.03 | 1,027 | 21,598 | 145,253 | Dec 16, 2019, 06:09 PM |
WORBOYS PHILIP D | SVP, Research & Transl Science | Nov 20, 2019 | Option Exercise | $17.60 | 2,272 | 39,987 | 264,855 | Nov 22, 2019, 06:28 PM |
Winningham Rick E | Chief Executive Officer | Nov 20, 2019 | Option Exercise | $17.60 | 8,678 | 152,733 | 1,074,455 | Nov 22, 2019, 06:26 PM |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | Nov 20, 2019 | Option Exercise | $17.60 | 3,567 | 62,779 | 175,334 | Nov 22, 2019, 06:25 PM |
SABESAN VIJAY | SVP, Technical Operations | Nov 20, 2019 | Option Exercise | $17.60 | 1,473 | 25,925 | 146,280 | Nov 22, 2019, 06:24 PM |
PITZER KENNETH R | SVP, Prod Strat & Comm Plng | Nov 20, 2019 | Option Exercise | $17.60 | 2,272 | 39,987 | 259,834 | Nov 22, 2019, 06:23 PM |
PASQUALONE FRANK | SVP, Chief Comm Ops Officer | Nov 20, 2019 | Option Exercise | $17.60 | 2,447 | 43,067 | 318,312 | Nov 22, 2019, 06:22 PM |
HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | Nov 20, 2019 | Option Exercise | $17.60 | 2,692 | 47,379 | 231,276 | Nov 22, 2019, 06:20 PM |
BRADY ANN | President, TBIL | Nov 20, 2019 | Option Exercise | $17.60 | 1,073 | 18,885 | 71,111 | Nov 22, 2019, 06:18 PM |
WORBOYS PHILIP D | SVP, Translational Science | Aug 20, 2019 | Option Exercise | $21.51 | 2,272 | 48,871 | 267,127 | Aug 22, 2019, 06:08 PM |
Winningham Rick E | Chief Executive Officer | Aug 20, 2019 | Option Exercise | $21.51 | 8,678 | 186,664 | 1,083,133 | Aug 22, 2019, 06:07 PM |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | Aug 20, 2019 | Option Exercise | $21.51 | 3,084 | 66,337 | 178,901 | Aug 22, 2019, 06:06 PM |
SABESAN VIJAY | SVP, Technical Operations | Aug 20, 2019 | Option Exercise | $21.51 | 1,472 | 31,663 | 147,753 | Aug 22, 2019, 06:05 PM |
PITZER KENNETH R | SVP, Prod Strat & Comm Plng | Aug 20, 2019 | Option Exercise | $21.51 | 2,272 | 48,871 | 262,106 | Aug 22, 2019, 06:03 PM |
PASQUALONE FRANK | SVP, Chief Comm Ops Officer | Aug 20, 2019 | Option Exercise | $21.51 | 2,335 | 50,226 | 320,759 | Aug 22, 2019, 06:02 PM |
HEGDE SHARATHCHANDRA S | SVP, Research | Aug 20, 2019 | Option Exercise | $21.51 | 2,272 | 48,871 | 259,900 | Aug 22, 2019, 06:01 PM |
HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | Aug 20, 2019 | Option Exercise | $21.51 | 2,710 | 58,292 | 233,968 | Aug 22, 2019, 06:00 PM |
BRADY ANN | President, TBIL | Aug 20, 2019 | Option Exercise | $21.51 | 1,073 | 23,080 | 72,184 | Aug 22, 2019, 05:58 PM |
WORBOYS PHILIP D | SVP, Translational Science | May 20, 2019 | Option Exercise | $19.84 | 2,272 | 45,076 | 269,399 | May 22, 2019, 06:19 PM |
Winningham Rick E | Chief Executive Officer | May 20, 2019 | Option Exercise | $19.84 | 8,678 | 172,172 | 1,091,811 | May 22, 2019, 06:17 PM |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | May 20, 2019 | Option Exercise | $19.84 | 2,488 | 49,362 | 181,985 | May 22, 2019, 06:15 PM |
SABESAN VIJAY | SVP, Technical Operations | May 20, 2019 | Option Exercise | $19.84 | 1,474 | 29,244 | 149,225 | May 22, 2019, 06:13 PM |
PITZER KENNETH R | SVP, Prod Strat & Comm Plng | May 20, 2019 | Option Exercise | $19.84 | 2,272 | 45,076 | 264,378 | May 22, 2019, 06:11 PM |
PASQUALONE FRANK | SVP, Chief Comm Ops Officer | May 20, 2019 | Option Exercise | $19.84 | 1,604 | 31,823 | 323,094 | May 22, 2019, 06:09 PM |
HEGDE SHARATHCHANDRA S | SVP, Research | May 20, 2019 | Option Exercise | $19.84 | 2,272 | 45,076 | 262,172 | May 22, 2019, 06:07 PM |
HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | May 20, 2019 | Option Exercise | $19.84 | 2,705 | 53,667 | 236,678 | May 22, 2019, 06:05 PM |
BRADY ANN | President, TBIL | May 20, 2019 | Option Exercise | $19.84 | 1,073 | 21,288 | 73,257 | May 22, 2019, 06:03 PM |
O'Connor Donal | Director | May 17, 2019 | Sale | $20.19 | 2,673 | 53,968 | 27,571 | May 20, 2019, 06:02 PM |
O'Connor Donal | Director | May 16, 2019 | Sale | $21.00 | 1,327 | 27,867 | 30,244 | May 20, 2019, 06:02 PM |
HEGDE SHARATHCHANDRA S | SVP, Research | Mar 05, 2019 | Sale | $24.50 | 5,690 | 139,405 | 264,444 | Mar 06, 2019, 07:20 PM |
HEGDE SHARATHCHANDRA S | SVP, Research | Mar 04, 2019 | Sale | $25.06 | 3,343 | 83,764 | 270,134 | Mar 06, 2019, 07:20 PM |
WORBOYS PHILIP D | SVP, Translational Science | Feb 20, 2019 | Option Exercise | $27.00 | 3,986 | 107,622 | 270,644 | Feb 22, 2019, 06:27 PM |
Winningham Rick E | Chief Executive Officer | Feb 20, 2019 | Option Exercise | $27.00 | 13,477 | 363,879 | 1,099,462 | Feb 22, 2019, 06:25 PM |
SULIMAN SHEHNAAZ | SVP, Corp Dev & Strategy | Feb 20, 2019 | Option Exercise | $27.00 | 5,763 | 155,601 | 97,198 | Feb 22, 2019, 06:23 PM |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | Feb 20, 2019 | Option Exercise | $27.00 | 5,798 | 156,546 | 183,446 | Feb 22, 2019, 06:22 PM |
SABESAN VIJAY | SVP, Technical Operations | Feb 20, 2019 | Option Exercise | $27.00 | 4,568 | 123,336 | 149,672 | Feb 22, 2019, 06:20 PM |
PITZER KENNETH R | SVP, Prod Strat & Comm Plng | Feb 20, 2019 | Option Exercise | $27.00 | 3,674 | 99,198 | 266,650 | Feb 22, 2019, 06:18 PM |
PASQUALONE FRANK | SVP, Chief Comm Ops Officer | Feb 20, 2019 | Option Exercise | $27.00 | 4,919 | 132,813 | 323,671 | Feb 22, 2019, 06:16 PM |
HEGDE SHARATHCHANDRA S | SVP, Research | Feb 20, 2019 | Option Exercise | $27.00 | 3,770 | 101,790 | 273,477 | Feb 22, 2019, 06:15 PM |
HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | Feb 20, 2019 | Option Exercise | $27.00 | 7,778 | 210,006 | 239,383 | Feb 22, 2019, 06:13 PM |
BRADY ANN | President, TBIL | Feb 20, 2019 | Option Exercise | $27.00 | 3,023 | 81,621 | 74,330 | Feb 22, 2019, 06:11 PM |
WORBOYS PHILIP D | SVP, Translational Science | Nov 20, 2018 | Option Exercise | $24.79 | 4,373 | 108,407 | 162,380 | Nov 21, 2018, 05:48 PM |
Winningham Rick E | Chief Executive Officer | Nov 20, 2018 | Option Exercise | $24.79 | 15,557 | 385,658 | 795,939 | Nov 21, 2018, 05:47 PM |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | Nov 20, 2018 | Option Exercise | $24.79 | 7,006 | 173,679 | 76,994 | Nov 21, 2018, 05:46 PM |
PITZER KENNETH R | SVP, Prod Strat & Comm Plng | Nov 20, 2018 | Option Exercise | $24.79 | 3,908 | 96,879 | 158,074 | Nov 21, 2018, 05:45 PM |
PASQUALONE FRANK | SVP, Chief Comm Ops Officer | Nov 20, 2018 | Option Exercise | $24.79 | 5,735 | 142,171 | 216,340 | Nov 21, 2018, 05:45 PM |
HEGDE SHARATHCHANDRA S | SVP, Research | Nov 20, 2018 | Option Exercise | $24.79 | 4,063 | 100,722 | 164,997 | Nov 21, 2018, 05:44 PM |
HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | Nov 20, 2018 | Option Exercise | $24.79 | 7,368 | 182,653 | 134,911 | Nov 21, 2018, 05:43 PM |
GALA RENEE D | SVP, Chief Financial Officer | Nov 20, 2018 | Option Exercise | $24.79 | 6,697 | 166,019 | 157,657 | Nov 21, 2018, 05:42 PM |
WORBOYS PHILIP D | SVP, Translational Science | Sep 12, 2018 | Sale | $28.50 | 6,393 | 182,201 | 166,753 | Sep 14, 2018, 05:03 PM |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | Aug 27, 2018 | Sale | $27.71 | 7,119 | 197,282 | 84,000 | Aug 29, 2018, 06:24 PM |
WORBOYS PHILIP D | SVP, Translational Science | Aug 20, 2018 | Option Exercise | $26.95 | 5,508 | 148,441 | 173,146 | Aug 22, 2018, 07:35 PM |
Winningham Rick E | Chief Executive Officer | Aug 20, 2018 | Option Exercise | $26.95 | 15,557 | 419,261 | 904,063 | Aug 22, 2018, 07:35 PM |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | Aug 20, 2018 | Option Exercise | $26.95 | 7,005 | 188,785 | 91,119 | Aug 22, 2018, 07:34 PM |
PITZER KENNETH R | SVP, Prod Strat & Comm Plng | Aug 20, 2018 | Option Exercise | $26.95 | 5,043 | 135,909 | 161,982 | Aug 22, 2018, 07:34 PM |
PASQUALONE FRANK | SVP, Chief Comm Ops Officer | Aug 20, 2018 | Option Exercise | $26.95 | 5,735 | 154,558 | 222,075 | Aug 22, 2018, 07:33 PM |
HEGDE SHARATHCHANDRA S | SVP, Research | Aug 20, 2018 | Option Exercise | $26.95 | 5,198 | 140,086 | 169,060 | Aug 22, 2018, 07:33 PM |
HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | Aug 20, 2018 | Option Exercise | $26.95 | 6,683 | 180,107 | 142,279 | Aug 22, 2018, 07:33 PM |
GALA RENEE D | SVP, Chief Financial Officer | Aug 20, 2018 | Option Exercise | $26.95 | 6,695 | 180,430 | 164,354 | Aug 22, 2018, 07:32 PM |
GALA RENEE D | SVP, Chief Financial Officer | Aug 15, 2018 | Sale | $26.74 | 41,539 | 1,110,655 | 172,749 | Aug 16, 2018, 07:08 PM |
GALA RENEE D | SVP, Chief Financial Officer | Aug 14, 2018 | Sale | $27.74 | 2,204 | 61,136 | 212,588 | Aug 16, 2018, 07:08 PM |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | Aug 08, 2018 | Sale | $27.85 | 25,355 | 706,182 | 98,124 | Aug 09, 2018, 07:46 PM |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | Aug 07, 2018 | Sale | $28.33 | 5,945 | 168,393 | 127,606 | Aug 09, 2018, 07:46 PM |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | Jun 08, 2018 | Sale | $23.66 | 3,900 | 92,260 | 129,424 | Jun 08, 2018, 07:34 PM |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | Jun 06, 2018 | Sale | $24.09 | 10,140 | 244,268 | 133,324 | Jun 08, 2018, 07:34 PM |
MALKIEL BURTON G | Director | May 21, 2018 | Buy | $22.54 | 1,000 | 22,540 | 56,757 | May 23, 2018, 06:49 PM |
WORBOYS PHILIP D | SVP, Translational Science | May 20, 2018 | Option Exercise | $24.31 | 19,524 | 474,628 | 178,654 | May 22, 2018, 07:03 PM |
Winningham Rick E | Chief Executive Officer | May 20, 2018 | Option Exercise | $24.31 | 67,617 | 1,643,769 | 919,620 | May 22, 2018, 07:03 PM |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | May 20, 2018 | Option Exercise | $24.31 | 21,812 | 530,250 | 143,464 | May 22, 2018, 07:02 PM |
PITZER KENNETH R | SVP, Prod Strat & Comm Plng | May 20, 2018 | Option Exercise | $24.31 | 18,779 | 456,517 | 167,025 | May 22, 2018, 07:02 PM |
PASQUALONE FRANK | SVP, Chief Comm Ops Officer | May 20, 2018 | Option Exercise | $24.31 | 18,424 | 447,887 | 227,810 | May 22, 2018, 07:02 PM |
HEGDE SHARATHCHANDRA S | SVP, Research | May 20, 2018 | Option Exercise | $24.31 | 19,103 | 464,394 | 174,258 | May 22, 2018, 07:01 PM |
HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | May 20, 2018 | Option Exercise | $24.31 | 26,991 | 656,151 | 148,962 | May 22, 2018, 07:01 PM |
GALA RENEE D | SVP, Chief Financial Officer | May 20, 2018 | Option Exercise | $24.31 | 21,230 | 516,101 | 214,792 | May 22, 2018, 07:01 PM |
GALA RENEE D | SVP, Chief Financial Officer | May 18, 2018 | Sale | $24.29 | 10,000 | 242,877 | 236,022 | May 22, 2018, 07:01 PM |
WORBOYS PHILIP D | SVP, Translational Science | Feb 20, 2018 | Option Exercise | $29.09 | 4,566 | 132,825 | 163,563 | Feb 22, 2018, 05:42 PM |
Winningham Rick E | Chief Executive Officer | Feb 20, 2018 | Option Exercise | $29.09 | 13,005 | 378,315 | 881,372 | Feb 22, 2018, 05:42 PM |
SULIMAN SHEHNAAZ | SVP, Corp Dev & Strategy | Feb 20, 2018 | Option Exercise | $29.09 | 8,770 | 255,119 | 101,230 | Feb 22, 2018, 05:41 PM |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | Feb 20, 2018 | Option Exercise | $29.09 | 5,587 | 162,526 | 130,661 | Feb 22, 2018, 05:41 PM |
PITZER KENNETH R | SVP, Prod Strat & Comm Plng | Feb 20, 2018 | Option Exercise | $29.09 | 4,252 | 123,691 | 152,054 | Feb 22, 2018, 05:40 PM |
PASQUALONE FRANK | SVP, Chief Comm Ops Officer | Feb 20, 2018 | Option Exercise | $29.09 | 4,741 | 137,916 | 211,619 | Feb 22, 2018, 05:40 PM |
HEGDE SHARATHCHANDRA S | SVP, Research | Feb 20, 2018 | Option Exercise | $29.09 | 4,349 | 126,512 | 159,611 | Feb 22, 2018, 05:39 PM |
HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | Feb 20, 2018 | Option Exercise | $29.09 | 8,293 | 241,243 | 142,203 | Feb 22, 2018, 05:39 PM |
GALA RENEE D | SVP, Chief Financial Officer | Feb 20, 2018 | Option Exercise | $29.09 | 5,387 | 156,708 | 211,407 | Feb 22, 2018, 05:38 PM |
WORBOYS PHILIP D | SVP, Translational Science | Nov 20, 2017 | Option Exercise | $28.58 | 5,503 | 157,276 | 159,129 | Nov 22, 2017, 04:40 PM |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | Nov 20, 2017 | Option Exercise | $28.58 | 7,079 | 202,318 | 127,248 | Nov 22, 2017, 04:40 PM |
PITZER KENNETH R | SVP, Prod Strat & Comm Plng | Nov 20, 2017 | Option Exercise | $28.58 | 5,014 | 143,300 | 147,306 | Nov 22, 2017, 04:39 PM |
PASQUALONE FRANK | SVP, Chief Comm Ops Officer | Nov 20, 2017 | Option Exercise | $28.58 | 5,820 | 166,336 | 207,360 | Nov 22, 2017, 04:38 PM |
HEGDE SHARATHCHANDRA S | SVP, Research | Nov 20, 2017 | Option Exercise | $28.58 | 5,177 | 147,959 | 154,960 | Nov 22, 2017, 04:38 PM |
HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | Nov 20, 2017 | Option Exercise | $28.58 | 7,846 | 224,239 | 141,496 | Nov 22, 2017, 04:37 PM |
GALA RENEE D | SVP, Chief Financial Officer | Nov 20, 2017 | Option Exercise | $28.58 | 6,753 | 193,001 | 207,794 | Nov 22, 2017, 04:35 PM |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | Sep 06, 2017 | Sale | $30.77 | 14,670 | 451,350 | 134,327 | Sep 08, 2017, 06:53 PM |
PASQUALONE FRANK | SVP, Chief Comm Ops Officer | Aug 21, 2017 | Buy | $26.34 | 4,000 | 105,359 | 213,180 | Aug 23, 2017, 05:04 PM |
WORBOYS PHILIP D | SVP, Translational Science | Aug 20, 2017 | Option Exercise | $27.40 | 5,502 | 150,755 | 164,632 | Aug 22, 2017, 06:31 PM |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | Aug 20, 2017 | Option Exercise | $27.40 | 7,079 | 193,965 | 148,997 | Aug 22, 2017, 06:30 PM |
PITZER KENNETH R | SVP, Prod Strat & Comm Plng | Aug 20, 2017 | Option Exercise | $27.40 | 5,013 | 137,356 | 152,320 | Aug 22, 2017, 06:30 PM |
PASQUALONE FRANK | SVP, Chief Comm Ops Officer | Aug 20, 2017 | Option Exercise | $27.40 | 5,820 | 159,468 | 209,180 | Aug 22, 2017, 06:29 PM |
HEGDE SHARATHCHANDRA S | SVP, Research | Aug 20, 2017 | Option Exercise | $27.40 | 5,176 | 141,822 | 160,137 | Aug 22, 2017, 06:28 PM |
HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | Aug 20, 2017 | Option Exercise | $27.40 | 7,064 | 193,554 | 149,342 | Aug 22, 2017, 06:28 PM |
GALA RENEE D | SVP, Chief Financial Officer | Aug 20, 2017 | Option Exercise | $27.40 | 6,752 | 185,005 | 214,547 | Aug 22, 2017, 06:27 PM |
WHITESIDES GEORGE M | Director | Aug 11, 2017 | Buy | $24.69 | 4,000 | 98,764 | 4,000 | Aug 14, 2017, 08:00 PM |
MALKIEL BURTON G | Director | Aug 11, 2017 | Buy | $24.59 | 15,000 | 368,815 | 15,000 | Aug 14, 2017, 07:57 PM |
MALKIEL BURTON G | Director | Aug 11, 2017 | Buy | $24.59 | 15,000 | 368,854 | 47,571 | Aug 14, 2017, 07:57 PM |
Fore Henrietta | Director | Aug 11, 2017 | Buy | $23.99 | 6,000 | 143,932 | 24,000 | Aug 11, 2017, 06:33 PM |
Winningham Rick E | Chief Executive Officer | Aug 11, 2017 | Buy | $24.50 | 10,000 | 245,000 | 866,377 | Aug 11, 2017, 06:26 PM |
WORBOYS PHILIP D | SVP, Translational Science | May 20, 2017 | Option Exercise | $36.83 | 5,503 | 202,676 | 170,134 | May 23, 2017, 08:01 PM |
Winningham Rick E | Chief Executive Officer | May 20, 2017 | Option Exercise | $36.83 | 15,460 | 569,392 | 856,377 | May 23, 2017, 08:01 PM |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | May 20, 2017 | Option Exercise | $36.83 | 7,079 | 260,720 | 156,076 | May 23, 2017, 08:00 PM |
PITZER KENNETH R | SVP, Prod Strat & Comm Plng | May 20, 2017 | Option Exercise | $36.83 | 5,014 | 184,666 | 157,333 | May 23, 2017, 08:00 PM |
PASQUALONE FRANK | SVP, Chief Comm Ops Officer | May 20, 2017 | Option Exercise | $36.83 | 5,820 | 214,351 | 215,000 | May 23, 2017, 08:00 PM |
HEGDE SHARATHCHANDRA S | SVP, Research | May 20, 2017 | Option Exercise | $36.83 | 5,177 | 190,669 | 165,313 | May 23, 2017, 07:59 PM |
HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | May 20, 2017 | Option Exercise | $36.83 | 7,065 | 260,204 | 156,406 | May 23, 2017, 07:59 PM |
GALA RENEE D | SVP, Chief Financial Officer | May 20, 2017 | Option Exercise | $36.83 | 6,753 | 248,713 | 221,299 | May 23, 2017, 07:58 PM |
HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | Mar 07, 2017 | Sale | $30.80 | 424 | 13,059 | 163,471 | Mar 08, 2017, 06:11 PM |
HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | Mar 06, 2017 | Sale | $31.52 | 13,576 | 427,916 | 163,895 | Mar 08, 2017, 06:11 PM |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | Mar 03, 2017 | Sale | $31.86 | 26,829 | 854,772 | 161,453 | Mar 07, 2017, 07:05 PM |
WORBOYS PHILIP D | SVP, Translational Science | Feb 20, 2017 | Option Exercise | $33.78 | 10,397 | 351,211 | 173,935 | Feb 22, 2017, 07:08 PM |
Winningham Rick E | Chief Executive Officer | Feb 20, 2017 | Option Exercise | $33.78 | 33,264 | 1,123,658 | 870,135 | Feb 22, 2017, 07:08 PM |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | Feb 20, 2017 | Option Exercise | $33.78 | 12,440 | 420,223 | 188,282 | Feb 22, 2017, 07:07 PM |
PITZER KENNETH R | SVP, Prod Strat & Comm Plng | Feb 20, 2017 | Option Exercise | $33.78 | 10,030 | 338,813 | 162,347 | Feb 22, 2017, 07:07 PM |
PASQUALONE FRANK | SVP Global Head Acute Care Bus | Feb 20, 2017 | Option Exercise | $33.78 | 8,762 | 295,980 | 219,118 | Feb 22, 2017, 07:07 PM |
LEE JUNNING | Sr. VP, Technical Operations | Feb 20, 2017 | Option Exercise | $33.78 | 9,611 | 324,660 | 225,071 | Feb 22, 2017, 07:06 PM |
HEGDE SHARATHCHANDRA S | SVP, Research | Feb 20, 2017 | Option Exercise | $33.78 | 10,138 | 342,462 | 170,490 | Feb 22, 2017, 07:06 PM |
HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | Feb 20, 2017 | Option Exercise | $33.78 | 14,434 | 487,581 | 177,471 | Feb 22, 2017, 07:06 PM |
GALA RENEE D | SVP, Chief Financial Officer | Feb 20, 2017 | Option Exercise | $33.78 | 10,211 | 344,928 | 226,350 | Feb 22, 2017, 07:05 PM |
WORBOYS PHILIP D | SVP, Translational Science | Nov 20, 2016 | Option Exercise | $31.96 | 2,104 | 67,244 | 175,332 | Nov 22, 2016, 06:07 PM |
Winningham Rick E | Chief Executive Officer | Nov 20, 2016 | Option Exercise | $31.96 | 8,360 | 267,186 | 875,399 | Nov 22, 2016, 06:06 PM |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | Nov 20, 2016 | Option Exercise | $31.96 | 4,008 | 128,096 | 191,722 | Nov 22, 2016, 06:04 PM |
PITZER KENNETH R | SVP, Prod Strat & Comm Plng | Nov 20, 2016 | Option Exercise | $31.96 | 1,727 | 55,195 | 163,377 | Nov 22, 2016, 06:04 PM |
LEE JUNNING | Sr. VP, Technical Operations | Nov 20, 2016 | Option Exercise | $31.96 | 3,785 | 120,969 | 234,682 | Nov 22, 2016, 06:03 PM |
HEGDE SHARATHCHANDRA S | SVP, Research | Nov 20, 2016 | Option Exercise | $31.96 | 1,845 | 58,966 | 171,628 | Nov 22, 2016, 06:03 PM |
HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | Nov 20, 2016 | Option Exercise | $31.96 | 5,388 | 172,200 | 182,905 | Nov 22, 2016, 06:02 PM |
GALA RENEE D | SVP, Chief Financial Officer | Nov 20, 2016 | Option Exercise | $31.96 | 4,628 | 147,911 | 227,561 | Nov 22, 2016, 06:01 PM |
HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | Aug 25, 2016 | Sale | $27.99 | 4,491 | 125,703 | 188,293 | Aug 25, 2016, 07:34 PM |
WORBOYS PHILIP D | SVP, Translational Science | Aug 20, 2016 | Option Exercise | $27.89 | 2,104 | 58,681 | 177,436 | Aug 23, 2016, 07:26 PM |
PITZER KENNETH R | SVP, Prod Strat & Comm Plng | Aug 20, 2016 | Option Exercise | $27.89 | 1,729 | 48,222 | 165,104 | Aug 23, 2016, 07:25 PM |
LEE JUNNING | Sr. VP, Technical Operations | Aug 20, 2016 | Option Exercise | $27.89 | 3,785 | 105,564 | 238,467 | Aug 23, 2016, 07:24 PM |
HEGDE SHARATHCHANDRA S | SVP, Research | Aug 20, 2016 | Option Exercise | $27.89 | 1,846 | 51,485 | 173,473 | Aug 23, 2016, 07:23 PM |
HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | Aug 20, 2016 | Option Exercise | $27.89 | 4,607 | 128,489 | 192,784 | Aug 23, 2016, 07:23 PM |
HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | Aug 19, 2016 | Sale | $27.97 | 9,509 | 265,967 | 197,391 | Aug 23, 2016, 07:23 PM |
GALA RENEE D | SVP, Chief Financial Officer | Aug 20, 2016 | Option Exercise | $27.89 | 4,306 | 120,094 | 232,189 | Aug 23, 2016, 07:22 PM |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | Aug 20, 2016 | Option Exercise | $27.89 | 4,008 | 111,783 | 232,808 | Aug 22, 2016, 07:08 PM |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | Aug 19, 2016 | Sale | $28.14 | 4,870 | 137,042 | 236,816 | Aug 22, 2016, 07:08 PM |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | Aug 18, 2016 | Sale | $28.55 | 7,174 | 204,818 | 241,686 | Aug 22, 2016, 07:08 PM |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | Aug 22, 2016 | Sale | $27.16 | 37,078 | 1,007,038 | 195,730 | Aug 22, 2016, 07:08 PM |
WORBOYS PHILIP D | SVP, Translational Science | May 20, 2016 | Option Exercise | $20.55 | 2,105 | 43,258 | 179,540 | May 24, 2016, 08:01 PM |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | May 20, 2016 | Option Exercise | $20.55 | 4,008 | 82,364 | 248,860 | May 24, 2016, 08:00 PM |
PITZER KENNETH R | SVP, Prod Strat & Comm Plng | May 20, 2016 | Option Exercise | $20.55 | 1,728 | 35,510 | 166,833 | May 24, 2016, 08:00 PM |
LEE JUNNING | Sr. VP, Technical Operations | May 20, 2016 | Option Exercise | $20.55 | 3,785 | 77,782 | 242,252 | May 24, 2016, 07:59 PM |
HEGDE SHARATHCHANDRA S | SVP, Research | May 20, 2016 | Option Exercise | $20.55 | 1,846 | 37,935 | 175,319 | May 24, 2016, 07:59 PM |
HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | May 20, 2016 | Option Exercise | $20.55 | 4,608 | 94,694 | 206,900 | May 24, 2016, 07:59 PM |
GALA RENEE D | SVP, Chief Financial Officer | May 20, 2016 | Option Exercise | $20.55 | 3,333 | 68,493 | 236,495 | May 24, 2016, 07:58 PM |
GLAXOSMITHKLINE PLC | 10% Owner | Mar 14, 2016 | Buy | $23028000.00 | 1,301,015 | 29,959,773,420,000 | 9,644,807 | Mar 15, 2016, 04:31 PM |
Shafer Bradford J | Sr VP, Gen. Counsel, Secretary | Feb 20, 2016 | Option Exercise | $15.65 | 18,920 | 296,098 | 136,165 | Feb 23, 2016, 07:59 PM |
GALA RENEE D | SVP, Chief Financial Officer | Feb 20, 2016 | Option Exercise | $15.65 | 13,052 | 204,264 | 148,125 | Feb 23, 2016, 07:58 PM |
Mammen Mathai | SVP, Research & Development | Feb 20, 2016 | Option Exercise | $15.65 | 19,844 | 310,559 | 198,111 | Feb 23, 2016, 07:58 PM |
LEE JUNNING | Sr. VP, Technical Operations | Feb 20, 2016 | Option Exercise | $15.65 | 16,049 | 251,167 | 154,335 | Feb 23, 2016, 07:57 PM |
HAUMANN BRETT K | SVP, Clinical Development | Feb 20, 2016 | Option Exercise | $15.65 | 18,425 | 288,351 | 121,508 | Feb 23, 2016, 07:56 PM |
BLUM LEONARD M | Sr VP, Chief Comm. Officer | Feb 20, 2016 | Option Exercise | $15.65 | 16,101 | 251,981 | 182,731 | Feb 23, 2016, 07:56 PM |
PASQUALONE FRANK | Sr. VP, Operations | Feb 20, 2016 | Option Exercise | $15.65 | 10,830 | 169,489 | 127,178 | Feb 23, 2016, 07:55 PM |
Shafer Bradford J | Sr VP, Gen. Counsel, Secretary | Nov 20, 2015 | Option Exercise | $17.17 | 934 | 16,037 | 155,085 | Nov 24, 2015, 07:37 PM |
Mammen Mathai | SVP, Research & Development | Nov 20, 2015 | Option Exercise | $17.17 | 934 | 16,037 | 217,955 | Nov 24, 2015, 07:37 PM |
LEE JUNNING | Sr. VP, Technical Operations | Nov 20, 2015 | Option Exercise | $17.17 | 1,037 | 17,805 | 170,384 | Nov 24, 2015, 07:36 PM |
HAUMANN BRETT K | SVP, Clinical Development | Nov 20, 2015 | Option Exercise | $17.17 | 781 | 13,410 | 139,933 | Nov 24, 2015, 07:36 PM |
GLAXOSMITHKLINE PLC | 10% Owner | Oct 07, 2015 | Buy | $607544.00 | 44,574 | 27,080,666,256 | 8,343,792 | Oct 07, 2015, 04:31 PM |
Mammen Mathai | SVP, Research & Development | Aug 20, 2015 | Option Exercise | $12.98 | 934 | 12,123 | 218,889 | Aug 24, 2015, 07:11 PM |
BLUM LEONARD M | Sr VP, Chief Comm. Officer | Aug 20, 2015 | Option Exercise | $12.98 | 934 | 12,123 | 198,832 | Aug 24, 2015, 07:11 PM |
Shafer Bradford J | Sr VP, Gen. Counsel, Secretary | Aug 20, 2015 | Option Exercise | $12.98 | 934 | 12,123 | 156,019 | Aug 24, 2015, 07:10 PM |
LEE JUNNING | Sr. VP, Technical Operations | Aug 18, 2015 | Buy | $12.90 | 9,000 | 116,100 | 9,000 | Aug 18, 2015, 08:30 PM |
MALKIEL BURTON G | Director | Aug 18, 2015 | Buy | $12.92 | 10,000 | 129,200 | 20,571 | Aug 18, 2015, 08:26 PM |
GALA RENEE D | SVP, Chief Financial Officer | Aug 17, 2015 | Buy | $12.16 | 5,000 | 60,800 | 161,177 | Aug 17, 2015, 07:21 PM |
GALA RENEE D | SVP, Chief Financial Officer | Aug 13, 2015 | Buy | $12.19 | 5,000 | 60,950 | 154,279 | Aug 17, 2015, 07:21 PM |
Winningham Rick E | Chief Executive Officer | Aug 17, 2015 | Buy | $12.13 | 16,860 | 204,512 | 602,056 | Aug 17, 2015, 07:21 PM |
Winningham Rick E | Chief Executive Officer | Aug 14, 2015 | Buy | $11.79 | 63,140 | 744,421 | 583,298 | Aug 17, 2015, 07:21 PM |
Shafer Bradford J | Sr VP, Gen. Counsel, Secretary | Jun 02, 2015 | Option Exercise | $13.83 | 7,360 | 101,789 | 156,953 | Jun 04, 2015, 07:14 PM |
Mammen Mathai | SVP, Research & Development | Jun 02, 2015 | Option Exercise | $13.83 | 7,360 | 101,789 | 219,823 | Jun 04, 2015, 07:14 PM |
LEE JUNNING | Sr. VP, Technical Operations | Jun 02, 2015 | Option Exercise | $13.83 | 5,152 | 71,252 | 169,720 | Jun 04, 2015, 07:13 PM |
BLUM LEONARD M | Sr VP, Chief Comm. Officer | Jun 02, 2015 | Option Exercise | $13.83 | 7,360 | 101,789 | 199,766 | Jun 04, 2015, 07:13 PM |
Shafer Bradford J | Sr VP, Gen. Counsel, Secretary | May 20, 2015 | Option Exercise | $14.24 | 673 | 9,584 | 164,313 | May 22, 2015, 07:16 PM |
LEE JUNNING | Sr. VP, Technical Operations | May 20, 2015 | Option Exercise | $14.24 | 748 | 10,652 | 174,872 | May 22, 2015, 07:16 PM |
BLUM LEONARD M | Sr VP, Chief Comm. Officer | May 20, 2015 | Option Exercise | $14.24 | 673 | 9,584 | 207,126 | May 22, 2015, 07:13 PM |
Mammen Mathai | SVP, Research & Development | May 20, 2015 | Option Exercise | $14.24 | 673 | 9,584 | 227,183 | May 22, 2015, 07:13 PM |
Shafer Bradford J | Sr VP, Gen. Counsel, Secretary | Feb 20, 2015 | Option Exercise | $19.52 | 674 | 13,156 | 163,088 | Feb 24, 2015, 06:55 PM |
Mammen Mathai | SVP, Research & Development | Feb 20, 2015 | Option Exercise | $19.52 | 674 | 13,156 | 227,856 | Feb 24, 2015, 06:55 PM |
LEE JUNNING | Sr. VP, Technical Operations | Feb 20, 2015 | Option Exercise | $19.52 | 970 | 18,934 | 175,620 | Feb 24, 2015, 06:54 PM |
BLUM LEONARD M | Sr VP, Chief Comm. Officer | Feb 20, 2015 | Option Exercise | $19.52 | 674 | 13,156 | 207,799 | Feb 24, 2015, 06:54 PM |
Winningham Rick E | Chief Executive Officer | Feb 20, 2015 | Option Exercise | $19.52 | 1,480 | 28,890 | 520,158 | Feb 24, 2015, 06:53 PM |
GALA RENEE D | SVP-Finance | Aug 20, 2014 | Option Exercise | $26.98 | 158 | 4,263 | 14,279 | Aug 22, 2014, 05:01 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
Owner | Relationship | Date | Value($) |
Samaha Eli | 10% Owner | 05/01/2024 | 13,117,335 |
Winningham Rick E | CHIEF EXECUTIVE OFFICER | 03/15/2024 | 23,363 |
Winningham Rick E | CHIEF EXECUTIVE OFFICER | 02/20/2024 | 331,788 |
Sawaf Aziz | SVP & CHIEF FINANCIAL OFFICER | 02/20/2024 | 151,961 |
Miller Aine | SVP, DEV & HEAD OF IRE OFFICE | 02/20/2024 | 105,095 |
Grimaud Brett A. | SVP, GEN COUNSEL AND SECRETARY | 02/20/2024 | 156,947 |
GRAHAM RICHARD A | SVP, RESEARCH & DEVELOPMENT | 02/20/2024 | 172,102 |
Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | 02/20/2024 | 162,513 |
Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | 02/22/2024 | 10,922 |
Winningham Rick E | CHIEF EXECUTIVE OFFICER | 11/20/2023 | 163,887 |
Sawaf Aziz | SVP & CHIEF FINANCIAL OFFICER | 11/20/2023 | 64,159 |
Grimaud Brett A. | SVP, GEN COUNSEL AND SECRETARY | 11/20/2023 | 76,354 |
GRAHAM RICHARD A | SVP, RESEARCH & DEVELOPMENT | 11/20/2023 | 130,973 |
Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | 11/20/2023 | 82,773 |
Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | 11/21/2023 | 14,180 |
GRAHAM RICHARD A | SVP, RESEARCH & DEVELOPMENT | 11/14/2023 | 25,366 |
GRAHAM RICHARD A | SVP, RESEARCH & DEVELOPMENT | 10/16/2023 | 22,412 |
GRAHAM RICHARD A | SVP, RESEARCH & DEVELOPMENT | 09/14/2023 | 24,547 |
Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | 08/22/2023 | 17,112 |
Winningham Rick E | CHIEF EXECUTIVE OFFICER | 08/20/2023 | 153,299 |
Sawaf Aziz | SVP & CHIEF FINANCIAL OFFICER | 08/20/2023 | 69,006 |
Grimaud Brett A. | SVP, GEN COUNSEL AND SECRETARY | 08/20/2023 | 86,446 |
GRAHAM RICHARD A | SVP, RESEARCH & DEVELOPMENT | 08/20/2023 | 101,472 |
Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | 08/20/2023 | 101,462 |
GRAHAM RICHARD A | SVP, RESEARCH & DEVELOPMENT | 08/11/2023 | 23,197 |
GRAHAM RICHARD A | SVP, RESEARCH & DEVELOPMENT | 07/14/2023 | 22,848 |
GRAHAM RICHARD A | SVP, RESEARCH & DEVELOPMENT | 06/14/2023 | 24,822 |
Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | 06/08/2023 | 19,923 |
Winningham Rick E | CHIEF EXECUTIVE OFFICER | 05/20/2023 | 177,163 |
Sawaf Aziz | SVP & CHIEF FINANCIAL OFFICER | 05/20/2023 | 98,020 |
Grimaud Brett A. | SVP, GEN COUNSEL AND SECRETARY | 05/20/2023 | 128,567 |
GRAHAM RICHARD A | SVP, RESEARCH & DEVELOPMENT | 05/20/2023 | 117,257 |
Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | 05/20/2023 | 62,406 |
GRAHAM RICHARD A | SVP, RESEARCH & DEVELOPMENT | 05/15/2023 | 26,146 |
GRAHAM RICHARD A | SVP, RESEARCH & DEVELOPMENT | 04/14/2023 | 27,597 |
GRAHAM RICHARD A | SVP, RESEARCH & DEVELOPMENT | 03/14/2023 | 23,973 |
Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | 03/09/2023 | 40,800 |
GRAHAM RICHARD A | SVP, RESEARCH & DEVELOPMENT | 03/06/2023 | 23,346 |
Winningham Rick E | CHIEF EXECUTIVE OFFICER | 02/20/2023 | 390,665 |
Sawaf Aziz | SVP & CHIEF FINANCIAL OFFICER | 02/20/2023 | 70,815 |
Grimaud Brett A. | SVP, GEN COUNSEL AND SECRETARY | 02/20/2023 | 106,467 |
GRAHAM RICHARD A | SVP, RESEARCH & DEVELOPMENT | 02/20/2023 | 125,875 |
Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | 02/20/2023 | 74,322 |
Winningham Rick E | CHIEF EXECUTIVE OFFICER | 12/14/2022 | 559,500 |
GRAHAM RICHARD A | SVP, RESEARCH & DEVELOPMENT | 12/01/2022 | 22,361 |
O'Connor Donal | Director | 11/22/2022 | 105,000 |
Winningham Rick E | CHIEF EXECUTIVE OFFICER | 11/20/2022 | 171,473 |
Hindman Andrew A. | SVP, CHIEF FINANCIAL OFFICER | 11/20/2022 | 271,868 |
Hindman Andrew A. | SVP, CHIEF FINANCIAL OFFICER | 11/18/2022 | 716,242 |
GRAHAM RICHARD A | SVP, RESEARCH & DEVELOPMENT | 11/20/2022 | 296,748 |
Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | 11/20/2022 | 252,458 |
GRAHAM RICHARD A | SVP, RESEARCH & DEVELOPMENT | 11/16/2022 | 31,360 |
GSK PLC | Former 10% Owner | 09/16/2022 | 94,036,868 |
Winningham Rick E | CHIEF EXECUTIVE OFFICER | 08/19/2022 | 147,609 |
Hindman Andrew A. | SVP, CHIEF FINANCIAL OFFICER | 08/19/2022 | 239,814 |
GRAHAM RICHARD A | SVP, DEVELOPMENT | 08/19/2022 | 177,376 |
Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | 08/19/2022 | 97,257 |
GRAHAM RICHARD A | SVP, DEVELOPMENT | 08/16/2022 | 47,640 |
GRAHAM RICHARD A | SVP, DEVELOPMENT | 08/09/2022 | 132,606 |
Winningham Rick E | CHIEF EXECUTIVE OFFICER | 05/20/2022 | 96,358 |
Hindman Andrew A. | SVP, CHIEF FINANCIAL OFFICER | 05/20/2022 | 29,410 |
GRAHAM RICHARD A | SVP, DEVELOPMENT | 05/20/2022 | 34,497 |
Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | 05/20/2022 | 19,228 |
Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | 05/23/2022 | 9,653 |
Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | 02/28/2022 | 23,947 |
Winningham Rick E | CHIEF EXECUTIVE OFFICER | 02/18/2022 | 218,243 |
PITZER KENNETH R | SVP, PROD STRAT & COMM PLNG | 02/18/2022 | 262,343 |
Hindman Andrew A. | SVP, CHIEF FINANCIAL OFFICER | 02/18/2022 | 249,601 |
GRAHAM RICHARD A | SVP, DEVELOPMENT | 02/18/2022 | 195,823 |
Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | 02/18/2022 | 113,629 |
BRADY ANN | PRESIDENT, TBIL | 02/18/2022 | 80,426 |
BRADY ANN | PRESIDENT, TBIL | 11/19/2021 | 26,493 |
PASQUALONE FRANK | SVP, CHIEF BUSINESS OFFICER | 11/19/2021 | 31,592 |
PITZER KENNETH R | SVP, PROD STRAT & COMM PLNG | 11/19/2021 | 36,032 |
GRAHAM RICHARD A | SVP, DEVELOPMENT | 11/19/2021 | 35,639 |
Hindman Andrew A. | SVP, CHIEF FINANCIAL OFFICER | 11/19/2021 | 11,286 |
WORBOYS PHILIP D | SVP, RESEARCH & TRANSL SCIENCE | 11/19/2021 | 36,032 |
SABESAN VIJAY | SVP, TECHNICAL OPERATIONS | 11/19/2021 | 43,397 |
Winningham Rick E | CHIEF EXECUTIVE OFFICER | 11/19/2021 | 95,337 |
WORBOYS PHILIP D | SVP, Research & Transl Science | 08/20/2021 | 60,513 |
Winningham Rick E | Chief Executive Officer | 08/20/2021 | 160,226 |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | 08/20/2021 | 60,513 |
SABESAN VIJAY | SVP, Technical Operations | 08/20/2021 | 72,962 |
PITZER KENNETH R | SVP, Prod Strat & Comm Plng | 08/20/2021 | 60,513 |
PASQUALONE FRANK | SVP, Chief Business Officer | 08/20/2021 | 53,095 |
Hindman Andrew A. | SVP, Chief Financial Officer | 08/20/2021 | 245,369 |
GRAHAM RICHARD A | SVP, Development | 08/20/2021 | 95,807 |
BRADY ANN | President, TBIL | 08/20/2021 | 44,524 |
Winningham Rick E | Chief Executive Officer | 05/20/2021 | 202,991 |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | 05/20/2021 | 76,718 |
GRAHAM RICHARD A | SVP, Development | 05/20/2021 | 60,698 |
BRADY ANN | President, TBIL | 05/20/2021 | 56,408 |
WORBOYS PHILIP D | SVP, Research & Transl Science | 03/09/2021 | 176,580 |
WORBOYS PHILIP D | SVP, Research & Transl Science | 02/20/2021 | 599,157 |
Winningham Rick E | Chief Executive Officer | 02/20/2021 | 2,073,439 |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | 02/20/2021 | 598,819 |
SABESAN VIJAY | SVP, Technical Operations | 02/20/2021 | 156,765 |
PITZER KENNETH R | SVP, Prod Strat & Comm Plng | 02/20/2021 | 599,984 |
PASQUALONE FRANK | SVP, Chief Business Officer | 02/20/2021 | 506,597 |
Hindman Andrew A. | SVP, Chief Financial Officer | 02/20/2021 | 74,859 |
HAUMANN BRETT K | Chief Medical Officer | 02/20/2021 | 670,277 |
GRAHAM RICHARD A | SVP, Development | 02/20/2021 | 123,958 |
BRADY ANN | President, TBIL | 02/20/2021 | 189,629 |
GRAHAM RICHARD A | SVP, Development | 12/14/2020 | 146,058 |
WORBOYS PHILIP D | SVP, Research & Transl Science | 12/03/2020 | 76,428 |
WORBOYS PHILIP D | SVP, Research & Transl Science | 11/20/2020 | 82,728 |
Winningham Rick E | Chief Executive Officer | 11/20/2020 | 240,011 |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | 11/20/2020 | 82,728 |
SABESAN VIJAY | SVP, Technical Operations | 11/20/2020 | 65,364 |
PITZER KENNETH R | SVP, Prod Strat & Comm Plng | 11/20/2020 | 82,728 |
PASQUALONE FRANK | SVP, Chief Comm Ops Officer | 11/20/2020 | 72,523 |
HAUMANN BRETT K | Chief Medical Officer | 11/20/2020 | 79,837 |
GRAHAM RICHARD A | SVP, Development | 11/20/2020 | 66,706 |
BRADY ANN | President, TBIL | 11/20/2020 | 39,445 |
WORBOYS PHILIP D | SVP, Research & Transl Science | 08/20/2020 | 87,529 |
WORBOYS PHILIP D | SVP, Research & Transl Science | 08/20/2020 | 307,854 |
Winningham Rick E | Chief Executive Officer | 08/20/2020 | 254,096 |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | 08/20/2020 | 87,529 |
SABESAN VIJAY | SVP, Technical Operations | 08/20/2020 | 69,218 |
PITZER KENNETH R | SVP, Prod Strat & Comm Plng | 08/20/2020 | 87,529 |
PASQUALONE FRANK | SVP, Chief Comm Ops Officer | 08/20/2020 | 76,779 |
Hindman Andrew A. | SVP, Chief Financial Officer | 08/20/2020 | 78,765 |
HAUMANN BRETT K | Chief Medical Officer | 08/20/2020 | 84,650 |
HAUMANN BRETT K | Chief Medical Officer | 08/21/2020 | 457,240 |
GRAHAM RICHARD A | SVP, Development | 08/20/2020 | 120,216 |
BRADY ANN | President, TBIL | 08/20/2020 | 41,760 |
WORBOYS PHILIP D | SVP, Research & Transl Science | 05/20/2020 | 128,203 |
Winningham Rick E | Chief Executive Officer | 05/20/2020 | 371,940 |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | 05/20/2020 | 128,203 |
SABESAN VIJAY | SVP, Technical Operations | 05/20/2020 | 101,373 |
PITZER KENNETH R | SVP, Prod Strat & Comm Plng | 05/20/2020 | 128,203 |
PASQUALONE FRANK | SVP, Chief Comm Ops Officer | 05/20/2020 | 112,387 |
HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | 05/20/2020 | 112,334 |
BRADY ANN | President, TBIL | 05/20/2020 | 61,128 |
WORBOYS PHILIP D | SVP, Research & Transl Science | 02/20/2020 | 753,819 |
Winningham Rick E | Chief Executive Officer | 02/20/2020 | 2,508,415 |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | 02/20/2020 | 761,512 |
SABESAN VIJAY | SVP, Technical Operations | 02/20/2020 | 186,817 |
PITZER KENNETH R | SVP, Prod Strat & Comm Plng | 02/20/2020 | 754,622 |
PASQUALONE FRANK | SVP, Chief Comm Ops Officer | 02/20/2020 | 631,753 |
Hindman Andrew A. | SVP, Chief Financial Officer | 02/20/2020 | 182,854 |
HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | 02/20/2020 | 870,447 |
BRADY ANN | President, TBIL | 02/20/2020 | 154,053 |
SABESAN VIJAY | SVP, Technical Operations | 12/12/2019 | 21,598 |
WORBOYS PHILIP D | SVP, Research & Transl Science | 11/20/2019 | 39,987 |
Winningham Rick E | Chief Executive Officer | 11/20/2019 | 152,733 |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | 11/20/2019 | 62,779 |
SABESAN VIJAY | SVP, Technical Operations | 11/20/2019 | 25,925 |
PITZER KENNETH R | SVP, Prod Strat & Comm Plng | 11/20/2019 | 39,987 |
PASQUALONE FRANK | SVP, Chief Comm Ops Officer | 11/20/2019 | 43,067 |
HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | 11/20/2019 | 47,379 |
BRADY ANN | President, TBIL | 11/20/2019 | 18,885 |
WORBOYS PHILIP D | SVP, Translational Science | 08/20/2019 | 48,871 |
Winningham Rick E | Chief Executive Officer | 08/20/2019 | 186,664 |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | 08/20/2019 | 66,337 |
SABESAN VIJAY | SVP, Technical Operations | 08/20/2019 | 31,663 |
PITZER KENNETH R | SVP, Prod Strat & Comm Plng | 08/20/2019 | 48,871 |
PASQUALONE FRANK | SVP, Chief Comm Ops Officer | 08/20/2019 | 50,226 |
HEGDE SHARATHCHANDRA S | SVP, Research | 08/20/2019 | 48,871 |
HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | 08/20/2019 | 58,292 |
BRADY ANN | President, TBIL | 08/20/2019 | 23,080 |
WORBOYS PHILIP D | SVP, Translational Science | 05/20/2019 | 45,076 |
Winningham Rick E | Chief Executive Officer | 05/20/2019 | 172,172 |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | 05/20/2019 | 49,362 |
SABESAN VIJAY | SVP, Technical Operations | 05/20/2019 | 29,244 |
PITZER KENNETH R | SVP, Prod Strat & Comm Plng | 05/20/2019 | 45,076 |
PASQUALONE FRANK | SVP, Chief Comm Ops Officer | 05/20/2019 | 31,823 |
HEGDE SHARATHCHANDRA S | SVP, Research | 05/20/2019 | 45,076 |
HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | 05/20/2019 | 53,667 |
BRADY ANN | President, TBIL | 05/20/2019 | 21,288 |
O'Connor Donal | Director | 05/17/2019 | 53,968 |
O'Connor Donal | Director | 05/16/2019 | 27,867 |
HEGDE SHARATHCHANDRA S | SVP, Research | 03/05/2019 | 139,405 |
HEGDE SHARATHCHANDRA S | SVP, Research | 03/04/2019 | 83,764 |
WORBOYS PHILIP D | SVP, Translational Science | 02/20/2019 | 107,622 |
Winningham Rick E | Chief Executive Officer | 02/20/2019 | 363,879 |
SULIMAN SHEHNAAZ | SVP, Corp Dev & Strategy | 02/20/2019 | 155,601 |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | 02/20/2019 | 156,546 |
SABESAN VIJAY | SVP, Technical Operations | 02/20/2019 | 123,336 |
PITZER KENNETH R | SVP, Prod Strat & Comm Plng | 02/20/2019 | 99,198 |
PASQUALONE FRANK | SVP, Chief Comm Ops Officer | 02/20/2019 | 132,813 |
HEGDE SHARATHCHANDRA S | SVP, Research | 02/20/2019 | 101,790 |
HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | 02/20/2019 | 210,006 |
BRADY ANN | President, TBIL | 02/20/2019 | 81,621 |
WORBOYS PHILIP D | SVP, Translational Science | 11/20/2018 | 108,407 |
Winningham Rick E | Chief Executive Officer | 11/20/2018 | 385,658 |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | 11/20/2018 | 173,679 |
PITZER KENNETH R | SVP, Prod Strat & Comm Plng | 11/20/2018 | 96,879 |
PASQUALONE FRANK | SVP, Chief Comm Ops Officer | 11/20/2018 | 142,171 |
HEGDE SHARATHCHANDRA S | SVP, Research | 11/20/2018 | 100,722 |
HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | 11/20/2018 | 182,653 |
GALA RENEE D | SVP, Chief Financial Officer | 11/20/2018 | 166,019 |
WORBOYS PHILIP D | SVP, Translational Science | 09/12/2018 | 182,201 |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | 08/27/2018 | 197,282 |
WORBOYS PHILIP D | SVP, Translational Science | 08/20/2018 | 148,441 |
Winningham Rick E | Chief Executive Officer | 08/20/2018 | 419,261 |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | 08/20/2018 | 188,785 |
PITZER KENNETH R | SVP, Prod Strat & Comm Plng | 08/20/2018 | 135,909 |
PASQUALONE FRANK | SVP, Chief Comm Ops Officer | 08/20/2018 | 154,558 |
HEGDE SHARATHCHANDRA S | SVP, Research | 08/20/2018 | 140,086 |
HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | 08/20/2018 | 180,107 |
GALA RENEE D | SVP, Chief Financial Officer | 08/20/2018 | 180,430 |
GALA RENEE D | SVP, Chief Financial Officer | 08/15/2018 | 1,110,655 |
GALA RENEE D | SVP, Chief Financial Officer | 08/14/2018 | 61,136 |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | 08/08/2018 | 706,182 |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | 08/07/2018 | 168,393 |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | 06/08/2018 | 92,260 |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | 06/06/2018 | 244,268 |
MALKIEL BURTON G | Director | 05/21/2018 | 22,540 |
WORBOYS PHILIP D | SVP, Translational Science | 05/20/2018 | 474,628 |
Winningham Rick E | Chief Executive Officer | 05/20/2018 | 1,643,769 |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | 05/20/2018 | 530,250 |
PITZER KENNETH R | SVP, Prod Strat & Comm Plng | 05/20/2018 | 456,517 |
PASQUALONE FRANK | SVP, Chief Comm Ops Officer | 05/20/2018 | 447,887 |
HEGDE SHARATHCHANDRA S | SVP, Research | 05/20/2018 | 464,394 |
HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | 05/20/2018 | 656,151 |
GALA RENEE D | SVP, Chief Financial Officer | 05/20/2018 | 516,101 |
GALA RENEE D | SVP, Chief Financial Officer | 05/18/2018 | 242,877 |
WORBOYS PHILIP D | SVP, Translational Science | 02/20/2018 | 132,825 |
Winningham Rick E | Chief Executive Officer | 02/20/2018 | 378,315 |
SULIMAN SHEHNAAZ | SVP, Corp Dev & Strategy | 02/20/2018 | 255,119 |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | 02/20/2018 | 162,526 |
PITZER KENNETH R | SVP, Prod Strat & Comm Plng | 02/20/2018 | 123,691 |
PASQUALONE FRANK | SVP, Chief Comm Ops Officer | 02/20/2018 | 137,916 |
HEGDE SHARATHCHANDRA S | SVP, Research | 02/20/2018 | 126,512 |
HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | 02/20/2018 | 241,243 |
GALA RENEE D | SVP, Chief Financial Officer | 02/20/2018 | 156,708 |
WORBOYS PHILIP D | SVP, Translational Science | 11/20/2017 | 157,276 |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | 11/20/2017 | 202,318 |
PITZER KENNETH R | SVP, Prod Strat & Comm Plng | 11/20/2017 | 143,300 |
PASQUALONE FRANK | SVP, Chief Comm Ops Officer | 11/20/2017 | 166,336 |
HEGDE SHARATHCHANDRA S | SVP, Research | 11/20/2017 | 147,959 |
HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | 11/20/2017 | 224,239 |
GALA RENEE D | SVP, Chief Financial Officer | 11/20/2017 | 193,001 |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | 09/06/2017 | 451,350 |
PASQUALONE FRANK | SVP, Chief Comm Ops Officer | 08/21/2017 | 105,359 |
WORBOYS PHILIP D | SVP, Translational Science | 08/20/2017 | 150,755 |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | 08/20/2017 | 193,965 |
PITZER KENNETH R | SVP, Prod Strat & Comm Plng | 08/20/2017 | 137,356 |
PASQUALONE FRANK | SVP, Chief Comm Ops Officer | 08/20/2017 | 159,468 |
HEGDE SHARATHCHANDRA S | SVP, Research | 08/20/2017 | 141,822 |
HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | 08/20/2017 | 193,554 |
GALA RENEE D | SVP, Chief Financial Officer | 08/20/2017 | 185,005 |
WHITESIDES GEORGE M | Director | 08/11/2017 | 98,764 |
MALKIEL BURTON G | Director | 08/11/2017 | 368,815 |
MALKIEL BURTON G | Director | 08/11/2017 | 368,854 |
Fore Henrietta | Director | 08/11/2017 | 143,932 |
Winningham Rick E | Chief Executive Officer | 08/11/2017 | 245,000 |
WORBOYS PHILIP D | SVP, Translational Science | 05/20/2017 | 202,676 |
Winningham Rick E | Chief Executive Officer | 05/20/2017 | 569,392 |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | 05/20/2017 | 260,720 |
PITZER KENNETH R | SVP, Prod Strat & Comm Plng | 05/20/2017 | 184,666 |
PASQUALONE FRANK | SVP, Chief Comm Ops Officer | 05/20/2017 | 214,351 |
HEGDE SHARATHCHANDRA S | SVP, Research | 05/20/2017 | 190,669 |
HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | 05/20/2017 | 260,204 |
GALA RENEE D | SVP, Chief Financial Officer | 05/20/2017 | 248,713 |
HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | 03/07/2017 | 13,059 |
HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | 03/06/2017 | 427,916 |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | 03/03/2017 | 854,772 |
WORBOYS PHILIP D | SVP, Translational Science | 02/20/2017 | 351,211 |
Winningham Rick E | Chief Executive Officer | 02/20/2017 | 1,123,658 |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | 02/20/2017 | 420,223 |
PITZER KENNETH R | SVP, Prod Strat & Comm Plng | 02/20/2017 | 338,813 |
PASQUALONE FRANK | SVP Global Head Acute Care Bus | 02/20/2017 | 295,980 |
LEE JUNNING | Sr. VP, Technical Operations | 02/20/2017 | 324,660 |
HEGDE SHARATHCHANDRA S | SVP, Research | 02/20/2017 | 342,462 |
HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | 02/20/2017 | 487,581 |
GALA RENEE D | SVP, Chief Financial Officer | 02/20/2017 | 344,928 |
WORBOYS PHILIP D | SVP, Translational Science | 11/20/2016 | 67,244 |
Winningham Rick E | Chief Executive Officer | 11/20/2016 | 267,186 |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | 11/20/2016 | 128,096 |
PITZER KENNETH R | SVP, Prod Strat & Comm Plng | 11/20/2016 | 55,195 |
LEE JUNNING | Sr. VP, Technical Operations | 11/20/2016 | 120,969 |
HEGDE SHARATHCHANDRA S | SVP, Research | 11/20/2016 | 58,966 |
HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | 11/20/2016 | 172,200 |
GALA RENEE D | SVP, Chief Financial Officer | 11/20/2016 | 147,911 |
HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | 08/25/2016 | 125,703 |
WORBOYS PHILIP D | SVP, Translational Science | 08/20/2016 | 58,681 |
PITZER KENNETH R | SVP, Prod Strat & Comm Plng | 08/20/2016 | 48,222 |
LEE JUNNING | Sr. VP, Technical Operations | 08/20/2016 | 105,564 |
HEGDE SHARATHCHANDRA S | SVP, Research | 08/20/2016 | 51,485 |
HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | 08/20/2016 | 128,489 |
HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | 08/19/2016 | 265,967 |
GALA RENEE D | SVP, Chief Financial Officer | 08/20/2016 | 120,094 |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | 08/20/2016 | 111,783 |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | 08/19/2016 | 137,042 |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | 08/18/2016 | 204,818 |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | 08/22/2016 | 1,007,038 |
WORBOYS PHILIP D | SVP, Translational Science | 05/20/2016 | 43,258 |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | 05/20/2016 | 82,364 |
PITZER KENNETH R | SVP, Prod Strat & Comm Plng | 05/20/2016 | 35,510 |
LEE JUNNING | Sr. VP, Technical Operations | 05/20/2016 | 77,782 |
HEGDE SHARATHCHANDRA S | SVP, Research | 05/20/2016 | 37,935 |
HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | 05/20/2016 | 94,694 |
GALA RENEE D | SVP, Chief Financial Officer | 05/20/2016 | 68,493 |
GLAXOSMITHKLINE PLC | 10% Owner | 03/14/2016 | 29,959,773,420,000 |
Shafer Bradford J | Sr VP, Gen. Counsel, Secretary | 02/20/2016 | 296,098 |
GALA RENEE D | SVP, Chief Financial Officer | 02/20/2016 | 204,264 |
Mammen Mathai | SVP, Research & Development | 02/20/2016 | 310,559 |
LEE JUNNING | Sr. VP, Technical Operations | 02/20/2016 | 251,167 |
HAUMANN BRETT K | SVP, Clinical Development | 02/20/2016 | 288,351 |
BLUM LEONARD M | Sr VP, Chief Comm. Officer | 02/20/2016 | 251,981 |
PASQUALONE FRANK | Sr. VP, Operations | 02/20/2016 | 169,489 |
Shafer Bradford J | Sr VP, Gen. Counsel, Secretary | 11/20/2015 | 16,037 |
Mammen Mathai | SVP, Research & Development | 11/20/2015 | 16,037 |
LEE JUNNING | Sr. VP, Technical Operations | 11/20/2015 | 17,805 |
HAUMANN BRETT K | SVP, Clinical Development | 11/20/2015 | 13,410 |
GLAXOSMITHKLINE PLC | 10% Owner | 10/07/2015 | 27,080,666,256 |
Mammen Mathai | SVP, Research & Development | 08/20/2015 | 12,123 |
BLUM LEONARD M | Sr VP, Chief Comm. Officer | 08/20/2015 | 12,123 |
Shafer Bradford J | Sr VP, Gen. Counsel, Secretary | 08/20/2015 | 12,123 |
LEE JUNNING | Sr. VP, Technical Operations | 08/18/2015 | 116,100 |
MALKIEL BURTON G | Director | 08/18/2015 | 129,200 |
GALA RENEE D | SVP, Chief Financial Officer | 08/17/2015 | 60,800 |
GALA RENEE D | SVP, Chief Financial Officer | 08/13/2015 | 60,950 |
Winningham Rick E | Chief Executive Officer | 08/17/2015 | 204,512 |
Winningham Rick E | Chief Executive Officer | 08/14/2015 | 744,421 |
Shafer Bradford J | Sr VP, Gen. Counsel, Secretary | 06/02/2015 | 101,789 |
Mammen Mathai | SVP, Research & Development | 06/02/2015 | 101,789 |
LEE JUNNING | Sr. VP, Technical Operations | 06/02/2015 | 71,252 |
BLUM LEONARD M | Sr VP, Chief Comm. Officer | 06/02/2015 | 101,789 |
Shafer Bradford J | Sr VP, Gen. Counsel, Secretary | 05/20/2015 | 9,584 |
LEE JUNNING | Sr. VP, Technical Operations | 05/20/2015 | 10,652 |
BLUM LEONARD M | Sr VP, Chief Comm. Officer | 05/20/2015 | 9,584 |
Mammen Mathai | SVP, Research & Development | 05/20/2015 | 9,584 |
Shafer Bradford J | Sr VP, Gen. Counsel, Secretary | 02/20/2015 | 13,156 |
Mammen Mathai | SVP, Research & Development | 02/20/2015 | 13,156 |
LEE JUNNING | Sr. VP, Technical Operations | 02/20/2015 | 18,934 |
BLUM LEONARD M | Sr VP, Chief Comm. Officer | 02/20/2015 | 13,156 |
Winningham Rick E | Chief Executive Officer | 02/20/2015 | 28,890 |
GALA RENEE D | SVP-Finance | 08/20/2014 | 4,263 |
Load More Insider Transactions
FUNDS WITH A POSITION IN THERAVANCE BIOPHARMA INC
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
BAUPOST GROUP LLC/MA | 6,594,126 | 1.62% | -11.12% | Value |
BLACKROCK INC. | 4,208,337 | 0.00088% | -8.27% | Other |
GEODE CAPITAL MANAGEMENT, LLC | 967,452 | 0.0008% | -2.67% | Other |
D. E. SHAW & CO., INC. | 781,585 | 0.006% | -8.18% | Other |
TUDOR INVESTMENT CORP ET AL | 177,612 | 0.01% | 1661.5% | Event Driven, Other |
ROYCE & ASSOCIATES LP | 59,009 | 0.00472% | No change | Value |
BALYASNY ASSET MANAGEMENT L.P. | 31,285 | 0.00049% | New | Event Driven |
CHANGE IN SHARES OUTSTANDING FOR THERAVANCE BIOPHARMA INC
STOCK BUYBACKS FOR THERAVANCE BIOPHARMA INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
-5.75%
1Q
06/30/2023
-12.93%
2Q
03/31/2023
-21.58%
3Q
12/31/2022
-26.70%
4Q
09/30/2022
-34.65%
5Q
06/30/2022
-35.29%
6Q
03/31/2022
-34.41%
7Q
12/31/2021
-33.32%
8Q
09/30/2021
-32.92%
9Q
06/30/2021
-24.85%
10Q
03/31/2021
-23.48%
11Q
12/31/2020
-22.57%
12Q
09/30/2020
-22.04%
13Q
06/30/2020
-21.49%
14Q
03/31/2020
-17.01%
15Q
12/31/2019
-12.04%
16Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR THERAVANCE BIOPHARMA INC
LOADING...